Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-12-20
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Study in Patients With Lung Cancer
NCT01581346
Resistance Training in Lung Cancer Patients on Chemotherapy
NCT01130714
Lifestyle Modification Program for Lung Cancer Patients - A Pilot Study
NCT04105647
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
NCT03918538
The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
NCT07216209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional Group
Pulmonary exercises + Aerobic training, 40%-60% intensity 3 days/ week for 4 weeks
Aerobic training
Aerobic training ( with cycle ergometer, 5-minute warm-up 15 - 30 minute cycle +5 minute cooldown) 40%-60% intensity calculated through Karvonen formula 3 days/ week
Control group
Pulmonary exercises, 3 sessions per week and 3-5 repetitions in a session for 4 weeks.
Pulmonary Exercises
4 weeks protocol
1. Deep breathing Exercises\* 10 Reps 3 sets
2. Postural drainage (10 minutes \* 2 sets /day)
3. Incentive spirometry\* 10 Reps 3 sets
4. Bed activities (Active ankle and hand pumping exercise \* 10 Reps 3 sets)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic training
Aerobic training ( with cycle ergometer, 5-minute warm-up 15 - 30 minute cycle +5 minute cooldown) 40%-60% intensity calculated through Karvonen formula 3 days/ week
Pulmonary Exercises
4 weeks protocol
1. Deep breathing Exercises\* 10 Reps 3 sets
2. Postural drainage (10 minutes \* 2 sets /day)
3. Incentive spirometry\* 10 Reps 3 sets
4. Bed activities (Active ankle and hand pumping exercise \* 10 Reps 3 sets)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Participants are undergoing lung cancer chemotherapy Participant has the willingness to participate in training WHO physical fitness scores 0-1 Able to perform 6-minute walk test (6MWT) at baseline
Exclusion Criteria
* Patients with lung disease other than lung cancer
* Uncontrolled hypertension or unstable coronary artery disease.
* Severe OA, bone or CNS metastases.
* hemoglobin \<10 g/dL
* Lower than 3,500 white blood cells per microliter of blood
20 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehwish Waseem, MSPT(CPPT)
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Radiotherapy and Nuclear Medicine
Peshawar, KPK, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Davis KM, Kelly SP, Luta G, Tomko C, Miller AB, Taylor KL. The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors. Urology. 2014 Aug;84(2):300-6. doi: 10.1016/j.urology.2014.04.036. Epub 2014 Jun 26.
Vainshelboim B, Fox BD, Saute M, Sagie A, Yehoshua L, Fuks L, Schneer S, Kramer MR. Limitations in exercise and functional capacity in long-term postpneumonectomy patients. J Cardiopulm Rehabil Prev. 2015 Jan-Feb;35(1):56-64. doi: 10.1097/HCR.0000000000000085.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/01093 Muheebur Rehman
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.